| Company | Market cap | P/E | Revenue | Rev. growth | Net income | Cash | Debt | AI value |
|---|---|---|---|---|---|---|---|---|
| OPTUOptimum Communications, Inc. | $323.45M | — | $8.59B | -4.1% | -$1.87B | $1.3B | $26.55B | AI pending |
| PMTSCPI Card Group Inc. | $323.32M | 24.2× | $543.53M | +13.1% | $14.95M | $21.37M | $262.14M | AI pending |
| EVOXEvolution Global Acquisition Corp | $323.2M | — | — | — | — | $842.43K | — | AI pending |
| KOYNCSLM Digital Asset Acquisition Corp III, Ltd | $323.15M | 67.4× | — | — | — | $2.16M | — | AI pending |
| PRQRProQR Therapeutics N.V. | $323.13M | — | €15.91M | -15.9% | -€42.18M | €92.41M | €4.87M | AI pending |
| HRZNHorizon Technology Finance Corp | $323.1M | 14.7× | — | — | — | $135.01M | $402.44M | AI pending |
| TBITrueBlue, Inc. | $323.01M | — | $1.62B | +3.1% | -$47.96M | $23.25M | $82.4M | AI pending |
| OBIOOrchestra BioMed Holdings, Inc. | $322.16M | — | $33.48M | +1,169.2% | -$52.7M | $20.47M | $15M | AI pending |
| NREFNexPoint Real Estate Finance, Inc. | $321.92M | 7.3× | — | — | — | $6.38M | $771.2M | AI pending |
| CAESCantor Equity Partners VII, Inc. | $321.69M | — | — | — | — | $362.73K | — | AI pending |
| ALDFAldel Financial II Inc. | $321.68M | 47.6× | — | — | — | $283.11K | — | AI pending |
| MTCMmtec, Inc. | $321.67M | — | $807.5K | -56.8% | -$56.08M | $6.51M | $405.59K | AI pending |
| XNETXunlei Ltd | $321.25M | — | $462.41M | +42.5% | $1.05B | $157.02M | $75.62M | AI pending |
| VACIViking Acquisition Corp I | $320.79M | 115.3× | — | — | — | $711.81K | — | AI pending |
| PMTRPerimeter Acquisition Corp. I | $320.59M | 40.6× | — | — | — | $400.31K | $0 | AI pending |
| IACQIrenic Acquisition Corp. | $320.46M | — | — | — | — | $1.02M | — | AI pending |
| NNDMNano Dimension Ltd. | $320.1M | — | $102.44M | +77.3% | -$293.3M | $349.11M | $138K | AI pending |
| NHPNational Healthcare Properties, Inc. | $319.85M | — | $342.28M | -3.3% | -$57.69M | $245.7M | — | AI pending |
| POLEAndretti Acquisition Corp. II | $319.59M | 41.8× | — | — | — | $225.38K | — | AI pending |
| VNDAVanda Pharmaceuticals Inc. | $319.24M | — | $216.11M | +8.7% | -$220.47M | $55.88M | — | AI pending |